New MS Drugs: The Latest on Emerging Treatments

There is no cure for multiple sclerosis (MS), but disease-modifying therapies (DMTs) can delay disability and slow the condition's progression. They work by preventing the immune system's...

New drug gives hope for those with progressive multiple sclerosis - CBS News

As many as 400,000 Americans are believed to suffer from multiple sclerosis, and a new drug may provide relief from the most devastating form of MS

MS Medications: Injections, Infusions, and Oral Drugs

Multiple sclerosis (MS) drugs can modify disease progression, treat relapses, and more. Learn about over 50 MS drugs, like Tecfidera and Ocrevus.

Researchers see success in trial for first generic MS drug, paving way for more

For the first time, a generic version of a popular drug for multiple sclerosis (MS) was found to be safe and effective— which may set precedent for generic drug development for MS patients.

New drug target for MS? | Nature Reviews Drug Discovery

promising new target for the treatment of MS. RGMa was originally identified in the visual system, and is known to have a crucial role in the nervous system. The authors carried out an...

New drug for severe form of MS generates glimmer of hope

The reason that the new drug is generating so much interest, though, is that it’s the first time a therapy for primary progressive MS has had any impact at all.

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic - NPR

January 20, 2020 · 9:00 AM ET · By Sydney Lupkin ; "They are extremely expensive," says Ewing-Wilson. On average, the medicines cost $70,000 per year, according to a 2017 study. Some prices have increased fivefold from when the drugs were first approved by the Food and Drug Administration. Even with insurance, says Ewing-Wilson, patients can be left on the hook for anywhere from $3,000 to more than $50,000 a year. Some patients tell her they need to skip their medications altogether because they're unaffordable. ...

New MS drug could slow symptoms of 'untreatable' form of disease | Multiple sclerosis

A new drug for multiple sclerosis could slow the progression of symptoms of a form of the... It is thought about 100,000 people in the UK and 2,500,000 people worldwide have MS, a...

U.S. pauses new patients on Merck MS drug in blow to shares

Merck KGaA said on Wednesday the U.S. Food and Drug Administration (FDA) had paused the initiation of new patients on its multiple sclerosis evobrutinib drug, knocking the German drugmaker's share...

MS Patients May Soon Bypass Painful Injections

About 400,000 Americans have multiple sclerosis, and up until now, the only drugs offered to them to slow the course of the disease had to be injected or dripped into a vein. But soon, it seems, th...